Measuring the Impact of Integrating Maternal and Newborn HIV Testing With Childhood Immunization Services
NCT02479659 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2015-07-01
Summary
This randomized evaluation measured the impact of two levels of support for the integration of infant and postpartum maternal HIV testing with routine immunization services in Southern Zambia on the number of postpartum maternal HIV tests, infant HIV tests, and 1st dose diphtheria, pertussis, and tetanus (DPT1) vaccines.
Conditions
Interventions
- OTHER
-
HIV testing commodity reinforcement
HIV testing commodities were replenished directly (outside of the government supply) in the event of a stock-out by study staff. Treatment facilities were visited monthly to assess stock levels, and facility staff could contact study staff when stock levels were low.
- OTHER
-
Policy reinforcement meeting
District health officials met with facility staff to remind them of the current HIV testing policies for mothers and newborns in Zambia. Current policy states mothers with unknown or previously negative status should be tested every 3 months until the infant is 18 months of age. HIV-exposed newborns should be tested at 6 weeks and 6 months.
- OTHER
-
Opt-out HIV testing for mothers and newborns
Facility staff were instructed to examine the maternal HIV status on the under-five (U-5) or antenatal care (ANC) card for all infants attending their first U-5 visit and do the following: * If marked Confirmed Exposed (CE), the health care worker conducted the DBS test on the infant only. * If marked, Mother Status Unknown (MSU) or Confirmed Not Exposed (CNE) the mother or caregiver was asked if the mother had ever tested HIV-positive. If yes, a DBS was done on the infant only. If no, the mother was offered an HIV antibody test in an opt-out manner.
- OTHER
-
Operational support for service integration
The evaluation team worked with facility staff to identify efficient allocations of staff and tailor the order of services. A key component of the operational optimization was a new patient triaging approach that sorted patient U-5 cards into bins and used separate queues for three types of patients: 1) first visit infants (six weeks), 2) second visit or later infants who required immunizations and 3) infants who were scheduled to only receive growth monitoring.
- OTHER
-
Community sensitization
Health facility staff were instructed to communicate all aspects of the Comprehensive Intervention during ANC appointments, in-facility child birth deliveries, and postnatal care (PNC) visits. Additionally, at six week immunization visits, mothers and caregivers received group counseling on opt-out HIV screening service and the importance of regular HIV screening for mother and child health. Finally, the research team engaged Safe Motherhood Action Groups (SMAGs), community health workers (CHWs), and active neighborhood health committee members to further increase awareness in facility catchment areas. These community members completed low-touch community sensitization over changes that would be made to U-5 services.
Sponsors & Collaborators
-
Zambia Center for Applied Health Research and Development
collaborator OTHER -
Ministry of Health, Zambia
collaborator OTHER_GOV -
Minister of Community Development, Mother and Child Health, Zambia
collaborator OTHER -
Clinton Health Access Initiative Inc.
collaborator OTHER -
IDinsight
lead OTHER
Principal Investigators
-
Paul Wang, MPAID/MBA · IDinsight
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2014-03-31
- Completion
- 2014-05-31
More Related Trials
-
Impact of COVID-19 on Provision and Uptake of Prevention of Mother-to-child Transmission of HIV Services in Zimbabwe
NCT04782739 ·Status: COMPLETED
-
Preventing Unplanned Pregnancies in HIV Infected Zambian Couples
NCT00067522 ·Status: UNKNOWN ·Phase: NA
-
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
NCT00028145 ·Status: COMPLETED
-
Efficacy of HIV Post-Test Support for ANC in South Africa
NCT01683461 ·Status: COMPLETED ·Phase: NA
-
Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV
NCT01433185 ·Status: COMPLETED ·Phase: NA
-
Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment
NCT06267508 ·Status: RECRUITING
-
An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
NCT01836003 ·Status: COMPLETED ·Phase: NA
-
HIV Point-of-Care Test Evaluation in Infants
NCT02545296 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of HIV and Early Antiretroviral Therapy Initiation Among HIV-1 Infected Infants
NCT03133728 ·Status: COMPLETED
-
Leveraging Infant Visit PrEP INtegration & tasK Shifting to Improve Post-partum HIV Prevention in Malawi
NCT06506188 ·Status: RECRUITING ·Phase: NA
-
Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia
NCT00753324 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of Mentor Mothers on PMTCT Service Outcomes in Nigeria
NCT01936753 ·Status: COMPLETED ·Phase: NA
-
Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT?
NCT02070900 ·Status: UNKNOWN ·Phase: NA
-
Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission
NCT00115648 ·Status: COMPLETED ·Phase: PHASE3
-
Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ART
NCT03986099 ·Status: COMPLETED ·Phase: NA
-
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
NCT03048669 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns
NCT00006396 ·Status: COMPLETED ·Phase: PHASE3
-
Home-based Partner Education and Testing (HOPE) Study
NCT01784783 ·Status: COMPLETED ·Phase: NA
-
An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women
NCT04330989 ·Status: COMPLETED ·Phase: NA
-
The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study
NCT04087239 ·Status: ACTIVE_NOT_RECRUITING
-
Systems Analysis and Improvement to Optimize pMTCT
NCT02023658 ·Status: COMPLETED ·Phase: NA
-
A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
NCT00000750 ·Status: COMPLETED ·Phase: PHASE3
-
Primary HIV Prevention in Pregnant and Lactating Ugandan Women
NCT01882998 ·Status: COMPLETED ·Phase: NA
-
Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers
NCT00098163 ·Status: COMPLETED ·Phase: PHASE1
-
Neonatal HIV Early Infant Diagnosis (EID) Versus Standard of Care EID- Long Term Impact on inFant hEalth (LIFE)
NCT04032522 ·Status: COMPLETED